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ABSTRACT
Variation in the concentration of antioxidants and hormones of
maternal origin in the eggs of birds can have a profound influence on
offspring phenotype both prenatally and postnatally. Egg maternal
substances can have interacting effects, but experimental studies of
the consequences of the combined variation in the egg concentration
of such molecules are extremely rare, particularly as far as prenatal
stages are concerned. We manipulated the yolk concentration of
vitamin E and corticosterone, which are, respectively, the main
antioxidant and the main glucocorticoid hormone in bird eggs, both
independently and simultaneously, and we tested their separate and
combined effects on growth and oxidative status in the liver and in
the brain of yellow-legged gull (Larus michahellis) embryos. Egg
supplementation of relatively large physiological doses of
corticosterone depressed embryo growth (total body mass, tarsus
length and liver mass), whereas administration of vitamin E in
association with corticosterone restored normal growth. Vitamin E did
not affect embryo growth when administered alone. We further
analysed the independent and combined effects of vitamin E and
corticosterone on liver and brain total antioxidant capacity, the
concentration of reactive oxygen molecules and lipid peroxidation.
Vitamin E significantly reduced liver total antioxidant capacity, while
corticosterone depressed brain lipid peroxidation. Prenatal exposure
to vitamin E and corticosterone appears to have antagonistic effects
on body growth, although vitamin E is not limiting in yellow-legged gull
eggs. In combination with the results of previous experiments on the
same species applying smaller experimental doses or focusing on
the postnatal rather than prenatal life stages, our findings indicate that
the effects of a physiological increase in the egg concentration of
these substances can be life stage and dose specific, implying that
generalizing prenatal effects of egg compounds may not be feasible.
KEY WORDS: Antioxidant, Glucocorticoid hormone, Larus
michahellis, Egg maternal substance, Embryo development
INTRODUCTION
Cleidoic eggs of vertebrates are a sealed environment with very
limited exchange of materials with the outer environment. Egg
maternal substances are therefore the major source of materials to
sustain embryo development and physiological processes. While
some classes of egg components, like hormones and antioxidants
of maternal origin, are quantitatively minor, variation in their
concentration in the egg, even within physiological limits, can have
a major impact on embryo development and can carry over into
postnatal life, as well as into adulthood (Royle et al., 2001; Saino
et al., 2003; Groothuis et al., 2005, 2006; Rubolini et al., 2005,
2006a,b). Maternal transfer of several classes of compounds to the
eggs depends on maternal experience of environmental conditions.
For example, vitamins are acquired via the diet and may be available
to mothers in different amounts (Parolini et al., 2015), while
maternal hormones may be transmitted to the eggs in concentrations
that vary with ecological conditions (e.g. Saino et al., 2005;
Williams and Groothuis, 2015). Thus, the egg components of
maternal origin have the potential to mediate transgenerational
effects whereby conditions experienced by the mothers are
translated into phenotypic variation in the offspring (Mousseau
and Fox, 1998). Such early maternal effects, which may be adaptive
or, conversely, reflect constraints on the ability of mothers to
produce eggs of optimal composition, have therefore attracted the
interest not only of animal production and physiology researchers
but also of ecologists and evolutionary biologists. Importantly, egg
compounds are expected to act in concert on offspring development
and postnatal growth, and the effect of individual components is
therefore presumed to depend on the concomitant effect of other
components, as determined by their relative concentrations (Royle
et al., 2001; Surai, 2002; Possenti et al., 2017, 2018a,b). However,
the combined as opposed to the independent effects of egg
constituents have seldom been subjected to experimental analysis
(e.g. Giraudeau et al., 2016; Possenti et al., 2018a,b).
A major class of egg compounds of maternal origin, which can
profoundly impact on embryo development, is that of antioxidants,
which mainly act to prevent oxidative damage to embryo biological
molecules caused by intense metabolic activity during prenatal life
stages (Surai, 2002; Costantini, 2014). In birds, vitamin E,
comprising a class of compounds that includes tocopherols and
tocotrienols, is the quantitatively most relevant exogenous (i.e.
acquired through the diet) antioxidant of maternal origin in the egg
yolk (Surai, 2002). Experiments on the effects of vitamin E have
mainly focused on the postnatal stages and have been carried out on
domestic animals (e.g. poultry), mainly by administration to the
laying mothers, potentially generating confounding effects due to
the consequences of vitamin E administration on maternal
physiology, with potential cascading effects on egg components
other than vitamin E (Surai, 2002). Experiments where the
concentration of focal compounds is manipulated directly in ovo
within physiological limits allow such potentially confounding
effects to be circumvented (Groothuis et al., 2005).Received 7 January 2019; Accepted 24 April 2019
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Maternal egg steroid hormones are also functionally important in
regulating offspring growth and physiology, as shown by studies
where the concentration of androgens or corticosterone has been
manipulated directly in the egg (e.g. Eising and Groothuis, 2003;
Groothuis et al., 2005). Studies of corticosterone in particular have
shown that increased egg concentrations can impair postnatal
somatic growth and immune function, ultimately depressing
survival (Eriksen et al., 2003; Janczak et al., 2006; Rogers and
Deng, 2005; Rubolini et al., 2005; Saino et al., 2005; Henriksen
et al., 2011). By influencing growth rates or via other physiological
pathways, egg corticosterone, like other egg steroid hormones, is
considered to have the potential to affect offspring oxidative status
(Costantini, 2014, 2008; Costantini et al., 2011; Haussmann et al.,
2012; Stier et al., 2009; Monaghan, 2014). For this reason, the effect
of an increase in corticosterone levels on the oxidative status of the
offspring is expected to depend on the concomitant concentration of
antioxidants, including vitamin E (Possenti et al., 2018a,b).
Conversely, because antioxidants are often sequestered in order to
accomplish their physiological functions, the effect of an increase in
antioxidant concentration may depend of the concomitant action of
pro-oxidants as influenced by their concentration. However, the
concomitant effects of experimental manipulation of egg
components with potentially antagonistic effects has seldom been
investigated (Williams and Groothuis, 2015; Giraudeau et al., 2016;
Possenti et al., 2018a,b) and, to the best of our knowledge, no single
study of birds has focused on the effects at the embryonic stage.
In the present study, we therefore investigated the combined
effects of experimental manipulation of corticosterone and
vitamin E concentration on embryo morphology and oxidative
status in the yellow-legged gull (Larus michahellisNaumann 1840),
a species that has previously been subjected to experimental
investigation into the effects of diverse egg components in the wild
(e.g. Rubolini et al., 2005; Parolini et al., 2015, 2017a,b; Possenti
et al., 2017, 2018a,b).
In the single previous experiment focusing on the effect of
administration of vitamin E into the eggs on embryo phenotype, we
increased the concentration of vitamin E by one standard deviation
of the natural concentration (i.e. a dose half that used in the present
study) and found that body mass but not tarsus length at the
eggshell cracking stage (as considered in the present study) was
significantly increased relative to controls (Parolini et al., 2017a).
In that experiment, we found no significant effect of vitamin E
administration on total antioxidant capacity (TAC), concentration of
reactive oxygen molecular species, protein carbonylation or lipid
peroxidation both in the liver and in the brain (Parolini et al., 2017a).
In other experiments, we focused on the effects of vitamin E
administration in the egg on post-hatching, rather than pre-hatching
yellow-legged gull chick phenotype. An experimental increase in
vitamin E concentration in the egg by one standard deviation of the
natural concentration (see above) boosted post-hatching growth,
particularly of chicks from the third (last) laid eggs in a clutch,
consistent with expectations because last-laid eggs contain smaller
concentrations of vitamin E than first- and second-laid eggs
(Parolini et al., 2015). These experimental conditions also showed
a significant positive effect of egg vitamin E on plasma TAC and a
negative effect on the concentration of pro-oxidant molecules after
hatching, but no effect on protein carbonylation, lipid peroxidation
and telomere length (Parolini et al., 2017b). Importantly, the effect
of vitamin E can be dose dependent and large, yet physiological
doses may not have the same positive effects on offspring growth
and physiology as low doses, as previously documented (Surai,
2002; de Ayala et al., 2006).
In another experiment, we aimed at testing whether egg vitamin E
and corticosterone have antagonistic effects on postnatal
development and oxidative status, by increasing the egg
concentration of either or both compounds simultaneously by two
standard deviations (Possenti et al., 2018a,b). We found that
separate administration of corticosterone and vitamin E caused a
reduction of body mass 4 days after hatching but not at hatching,
whereas the combined administration of the two compounds
reversed these negative effects, suggesting that these two egg
components interact and their egg amounts must be balanced to
enhance offspring phenotypic quality (Possenti et al., 2018a,b).
Importantly, in that experiment (Possenti et al., 2018a,b), a larger
(but still physiological) dose than that used in the other experiments
was injected (Parolini et al., 2015, 2017a,b,c).
Because corticosterone and vitamin E can interact to alter
offspring phenotype, but these effects apparently differ even
between closely spaced life stages (see Parolini et al., 2017a,b), in
the present study we analysed the independent and combined effects
of vitamin E and corticosterone on morphology (embryo mass,
tarsus length, brain mass, liver mass) and oxidative status (TAC,
amount of pro-oxidant molecules and lipid peroxidation in the brain
and the liver) at the pre-hatching, embryonic stage. To this end, we
established three groups of eggs where, immediately after laying, we
increased the concentration of vitamin E alone, of corticosterone
alone, or of the two compounds simultaneously, by two standard
deviations of the natural concentration (i.e. within the natural limits
of variation). However, a recent study has demonstrated that the
concentrations of corticosterone in the yolk of the yellow-legged
gull reported by Rubolini et al. (2011) could be overestimated. For
this reason, the concentration we injected could be considered as
supraphysiological. In addition, we established an appropriate
control group of sham-inoculated eggs. Thus, the present study
provides novel information on the effect of a higher physiological
vitamin E dose than that applied by Parolini et al. (2017a) on
embryo growth and the oxidative status of two organs. This is
important because the effect of vitamin E can vary with its
concentration, within the physiological range of variation.
In addition, the present study provides entirely novel information
on the independent and combined effects of vitamin E and
corticosterone on pre-hatching embryo morphology and oxidative
status, a topic that has never been tackled experimentally in any
species before. We focused on embryos close to hatching because
the effects experienced during the prenatal developmental stage can
result in consequences in the early postnatal stage and adulthood.
Moreover, as our previous studies of the yellow-legged gull have
shown contrasting effects due to supplementation with a focal
antioxidant or putatively pro-oxidant molecule on different
phenotypic traits (Table 1), in the present study we aimed at
investigating whether the consequences on embryos of combined
vitamin E and corticosterone in ovo injection return dissimilar
results compared with those for hatchlings (Possenti et al., 2018a,b).
According to previous findings on the yellow-legged gull, we
expected that vitamin E treatment would enhance embryonic growth
(Parolini et al., 2017a), corticosterone treatment would depress it
(Rubolini et al., 2005), and treatment with both substances would
restore normal growth. As for the effect of the experimental
manipulations on oxidative status variables, we expected that
corticosterone would reduce TAC and increase the concentration of
reactive oxygen species (ROS) and lipid peroxidation, whereas
vitamin E treatment would have opposite effects and that treatment
with both compounds would restore the oxidative status observed
among controls.
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MATERIALS AND METHODS
Study species
The yellow-legged gull is a monogamous, semi-colonial
charadriiform (Cramp, 1998). Clutch size varies between 1 and 3,
with a modal size of 3 eggs, and eggs are laid at 1–3 days intervals.
Sibling eggs hatch asynchronously over 1–4 days, after 27–31 days
of incubation by both parents, and hatching order reflects laying
order. Egg size normally declines with laying order: third (c-) eggs
are considerably smaller than first (a-) and second (b-) laid eggs.
The concentration of yolk antioxidants and androgen hormones
varies according to the position in the laying sequence; specifically,
vitamin E yolk concentration declines with laying sequence. In
contrast, corticosterone concentration does not vary between first-,
second- and third-laid eggs (Rubolini et al., 2011).
General field procedures and egg manipulation
The study was performed in the Comacchio lagoon (44°20′N,
12°11′E, NE Italy) during spring 2017 with the permission of Parco
Regionale Delta del Po. We visited the colony every other day to
record and individually mark newly laid eggs. When a newly laid
egg was found, it was temporarily removed from its nest for
manipulation and replaced with a dummy egg in order to minimize
perturbation of the behaviour of the parents. The eggs were moved
to a nearby tent for manipulation procedures. We adopted a within-
clutch design whereby different treatment groups were established
within each clutch. This approach served to reduce the confounding
effects of among-clutch variation in egg quality and parental
incubation behaviour. Each egg was assigned to one of the
following treatments: control injection, injection with vitamin E
(VitE), injection with corticosterone (Cort), and injection with
vitamin E and corticosterone (VitE+Cort). Because, with very rare
exceptions, maximal clutch size in yellow-legged gulls is 3 eggs,
only three of the four treatment groups could be established in
each clutch. Thus, we assigned each clutch to different treatment
schemes according to the order in which the first egg of the clutch
was found (see Possenti et al., 2018a,b). Treatment schemes with
corticosterone and vitamin E plus corticosterone, and with vitamin
E and vitamin E plus corticosterone are shown in Table 2. We aimed
at increasing the concentration of both vitamin E and corticosterone
by 2 standard deviations of their concentrations recorded in the same
Table 1. Effect of in ovo injection of antioxidant and putatively pro-oxidantmolecules into the yolkon different phenotypic traits at prenatal (embryo)
and postnatal (hatchling) stages of the yellow-legged gull
Injected molecule Concentration range Developmental stage Phenotypic trait Effect Reference
Vitamin E 305–748 µg (+1 s.d.) Hatchlings Body mass + Parolini et al., 2015
Tarsus length +
Vitamin E 305–748 µg (+1 s.d.) Hatchling blood Total antioxidant capacity + Parolini et al., 2017b
Amount of pro-oxidant molecules +
Lipid peroxidation =
Protein carbonylation =
Telomere length =
Vitamin E 305–748 µg (+1 s.d.) Embryos Body mass + Parolini et al., 2017a
Tarsus length =
Embryo liver and brain Amount of pro-oxidant molecules =
Lipid peroxidation =
Protein carbonylation =
Corticosterone 33–75 ng (+1 s.d.) Hatchlings Begging frequency – Possenti et al., 2018a
Reversal-to-prone response =
Vitamin E 567–1392 µg (+2 s.d.) Hatchlings (0 days old) Body mass
Tarsus length
=
=
Possenti et al., 2018b
Hatchlings (4 days old) Body mass
Tarsus length
–
=
Corticosterone 66–150 ng (+2 s.d.) Hatchlings (0 days old) Body mass
Tarsus length
=
=
Hatchlings (4 days old) Body mass
Tarsus length
=
=
Total antioxidant capacity =
Amount of pro-oxidant molecules =
Vitamin E+corticosterone Vitamin E: 567–1392 µg
Corticosterone: 66–150 ng
(+2 s.d.)
Hatchlings (0 days old) Body mass
Tarsus length
=
=
Hatchlings (4 days old) Body mass
Tarsus length
=
=
Total antioxidant capacity +
Amount of pro-oxidant molecules =
‘+’ indicates a positive significant effect of yolk supplementation comparedwith the control group, ‘–’ indicates a negative significant effect of yolk supplementation
compared with the control group, and ‘=’ indicates a null non-significant effect of yolk supplementation compared with the control group on a specific
phenotypic trait.
Table 2. Clutch treatment scheme
Treatment Nest
Egg order
a b c
Corticosterone and vitamin E
plus corticosterone
1 VitE+Cort Cort Control
2 Cort VitE+Cort Control
3 Control Cort VitE+Cort
4 Control VitE+Cort Cort
5 Cort Control VitE+Cort
6 VitE+Cort Control Cort
Vitamin E and vitamin E plus
corticosterone
1 VitE+Cort VitE Control
2 VitE VitE+Cort Control
3 VitE+Cort VitE Cort
4 Control VitE VitE+Cort
5 VitE Control VitE+Cort
6 VitE+Cort Control VitE
The format was continued for subsequent nests. VitE, vitamin E; Cort,
corticosterone.
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colony in a previous study (Rubolini et al., 2011), so that the post-
manipulation concentration of both substances fell within the
natural range of variation in the vast majority of the eggs. However,
it is important to bear in mind that concentrations of corticosterone
reported by Rubolini et al. (2011) could be overestimated because of
a methodological limitation (see Larsen et al., 2015). A recent study
has shown that the yolk concentration of corticosterone in nine bird
species ranged between 0.1 and 0.53 ng g−1 (Merrill et al., 2018).
Moreover, analyses performed in liquid chromatography coupled
with tandem mass spectrometric detection (LC-MS/MS) have
revealed that in the eggs of the black-backed gull Larus fuscus, a
closely related species to the yellow-legged gull, the concentration
of corticosterone in the yolk reached 75 pg g−1 (Larsen et al., 2015).
Thus, the concentration we injected could be considered as
supraphysiological. Because the variance in the concentrations of
these substances differed both among position in the laying
sequence (for vitamin E only, not for corticosterone) and with
yolk mass, we decided to tune the amount of the substance for
injection based on both these variables. We grouped a-, b- and c-
eggs into three classes of egg mass (tertiles) and computed 2 s.d. of
the concentration of the substances within each class of laying order
and egg mass, based on data from Rubolini et al. (2011). We then
estimated yolk mass based on the equation yolk mass=0.227×egg
mass−1.815 (see Parolini et al., 2015; Possenti et al., 2018a,b). The
absolute amount of vitamin E and corticosterone for injection into
each individual egg was then computed as the product of the relevant
standard deviation value and the estimated yolk mass (Possenti et al.,
2018a,b). The absolute amounts of vitamin E and corticosterone that
were injected are reported in Possenti et al. (2018a,b). The doses of
vitamin E and corticosterone were dissolved in 30 µl corn oil. The
solutions for all the different laying order×egg mass classes of eggs
were prepared in advance and stored in sterile vials. A single vial was
used on each treatment day and then discarded. Control eggs were
injected with 30 µl corn oil. Details of the injection procedures have
been reported in previous studies performed by our group on the
yellow-legged gull (e.g. Parolini et al., 2015, 2017a,b; Possenti et al.,
2018a,b). Eggs were returned to their original nest when the egg
manipulation procedures were completed, within 2 h of collection,
and the dummy eggs were removed.
Nests were visited every second day throughout the incubation
period and daily starting around the time when the eggshell was
expected to start showing the typical minute fracturing that precedes
hatching. When the first signs of fracturing were observed, the eggs
were collected and stored frozen within 5 h of collection. Egg
collection occurred on average on day 24.2 after laying (1.5 s.d.).
Embryo morphological measurements
In the lab, we gently thawed eggs and, after removing the eggshell,
we detached and weighed the residual yolk sac from each embryo.
Then, the embryos wereweighed and tarsus length was measured by
callipers prior to dissection of the liver and the brain, which were
immediately weighed and frozen at −80°C until the analysis of
oxidative status markers. All the measurements were taken by
the same person to ensure consistency. Embryos were sexed
molecularly according to Saino et al. (2008).
Analysis of oxidative status markers in focal organs
TAC, the amount of pro-oxidant molecules and lipid peroxidation
were measured in both liver and brain homogenates according to the
methods reported in detail by Parolini et al. (2017a). A small piece of
brain or liver (∼ 0.1 g) was homogenized in 100 mmol l−1 phosphate
buffer with 1 mmol l−1 EDTA and 100 mmol l−1 KCl (pH 7.4), by an
automatic homogenizer. The homogenatewas centrifuged at 16,000 g
for 10 min and an aliquot of the obtained supernatant was processed
for protein content determination according to the Bradford method
(Bradford, 1976) using bovine serum albumin (BSA) as a standard.
The remaining supernatant was used for analysis of oxidative status
markers. Briefly, TAC was measured according to the method
developed by Erel (2004) based on the bleaching of 2,2′-azinobis-(3-
ethylbenzothiazoline-6-sulfonic acid) radical cation (ABTS·+) in
presence of antioxidant molecules within the sample. The amount of
pro-oxidant molecules was measured according to a colorimetric
method adapted by Erel (2005). The pro-oxidants in the sample
oxidize the ferrous ion–o-dianisidine complex to ferric ion, which
reacts with xylenol orange to produce a blue complex. Lipid
peroxidation was measured according to the thiobarbituric acid
reactive substances (TBARS) method (Ohkawa et al., 1979), adapted
to embryo tissue homogenates.
Statistical analysis
We mainly relied on linear mixed models (LMM) where
experimental treatment, sex and laying order were included as
fixed effect factors, with nest identity as a random effect factor. In the
analysis of morphological traits we also included in the models the
effect of original egg mass as a covariate. The two-way interactions
between factors were also initially included in the models. All the
non-significant interaction effectswere removed from themodels in a
single step, to reduce the numberof tests on the same variables, which
would have increased by a stepwise procedure. To reduce the risk of
incurring type I statistical errors due to multiple tests, we corrected
significance levels associated to the effect of factors by the false
discovery rate (FDR) procedure. Thus, for example, FDR correction
for the effect of egg treatment on embryo phenotype was applied to
the 10 tests performed on the 10 embryo phenotypic variables.
However, in investigating the effects of interactions between main
effects, we also relied on visual inspection of variation inmeanvalues
among groups (see also Results). This led to the retention of a single
(treatment×sex) interaction effect in the models of TAC in the liver
(see Results). Statistical parameters are reported with their associated
standard error unless otherwise specified. The experiment included
153 embryos from 59 nests. Of these embryos, 51 (29 males, 22
females) originated from control eggs, 23 (8, 15) from vitamin
E-injected eggs, 27 (17, 10) from corticosterone-injected eggs and 52
(21, 31) from eggs injected with vitamin E plus corticosterone.
For all these embryos, information on all morphological variables
was available. Statistically significant outliers (1–6 data points,
depending on considered assay and focal organ) were removed after
running Grubbs’ test (extreme studentized deviate method). Because
of the presence of significant outliers, however, the number of
embryos included in the analyses of oxidative status variables was
reduced to 147–152, depending on the specific variable considered.
Statistical analyses were performed with SPSS 21 software.
RESULTS
In a linearmixedmodelwith nest as a random factor, laying date did not
significantly vary among egg treatment groups (F3,149=0.03,P=0.992).
Similarly, eggs mass at laying did not significantly vary among groups
(F3,149=0.04, P=0.987). In addition, time elapsed between laying and
egg collection, which occurred when eggshell fracturing started to
become apparent, did not differ among experimental groups
(F3,145=0.09; P=0.967). Full statistics for the post hoc tests of
differences in least-squares means are provided in Table S1.
Egg treatment significantly affected total embryo mass, tarsus
length and liver mass but not brain mass, when controlling for sex,
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laying order and original egg mass (Table 3). Post hoc tests showed
that total body mass, tarsus length and liver mass of the embryos
from Cort eggs were smaller than those of the embryos from the
other experimental groups (Fig. 1). In addition, tarsus length of
the embryos from VitE eggs was larger than tarsus length of the
embryos from VitE+Cort eggs (Fig. 1). Moreover, liver mass of
control embryos was larger than liver mass of embryos from
VitE+Cort eggs (Fig. 1).
TAC in the liver was significantly affected by egg treatment (as a
main effect), with embryos from VitE eggs showing smaller
Table 3. Linear mixed models of embryo morphological traits in relation to egg treatment, sex and laying order
Morphological trait F d.f. P Males Females a-eggs b-eggs c-eggs Coefficient
Embryo body mass
Treatment 3.33 3145 0.0214*
Sex 0.15 1145 0.695 46.88 (0.41) 46.67 (0.41)
Laying order 2.62 2145 0.0761 46.99 (0.48) 47.42 (0.47) 45.92 (0.51)
Egg mass 111.34 1145 <0.0001 0.50 (0.05)
Tarsus length
Treatment 6.23 3145 0.0005*
Sex 1.54 1145 0.216 23.41 (0.21) 23.10 (0.21)
Laying order 7.02 2145 0.0012* 23.47 (0.24) 23.71 (0.23) 22.57 (0.26)
Egg mass 1.12 1145 0.291 0.03 (0.02)
Brain mass
Treatment 1.68 3145 0.175
Sex 9.37 1145 0.0026* 1.68 (0.02) 1.62 (0.02)
Laying order 9.86 2145 <0.0001* 1.69 (0.02) 1.67 (0.02) 1.59 (0.02)
Egg mass 0.97 1145 0.327 0.002 (0.002)
Liver mass
Treatment 5.32 3145 0.0017*
Sex 2.19 1145 0.141 0.98 (0.03) 0.93 (0.03)
Laying order 1.12 2145 0.329 0.99 (0.03) 0.95 (0.03) 0.93 (0.03)
Egg mass 0.97 1145 0.327 0.001 (0.003)
Egg treatments were: control, vitamin E, corticosterone, vitamin E+corticosterone. The non-significant two-way interaction terms between treatment, sex and
laying order were excluded from themodels in all cases. The least-squaresmeans (s.e.) for either sex or position in the laying sequence and the coefficient for egg
mass are reported. For least-squares means of the treatment groups, see Fig. 1. Asterisks indicate that the effect was statistically significant after false discovery
rate (FDR) correction.
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Fig. 1. Morphological variables of embryos from control eggs and eggs injected with vitamin E, corticosterone or vitamin E plus corticosterone.
(A) Body mass, (B) tarsus length, (C) brain mass and (D) liver mass. Data are means±s.e.m. Horizontal lines connect pairs of groups that significantly differed in
LSD post hoc tests. Numbers above histograms indicate sample size. VitE, vitamin E; Cort, corticosterone.
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antioxidant capacity than those from the other treatment groups
(Table 4). However, there was an indication that the effects of
treatment depended on sex, as shown by the treatment×sex
interaction (Table 4). The effect of the sex×treatment interaction
was in fact statistically significant before but not after FDR
correction. However, FDR correction entails a marked increase in
the risk of incurring type II statistical errors, and an inspection of the
group means (see Fig. 2B) does indeed suggest that variation
according to treatment depended on sex and that the relatively weak
effect was due to large variance and small sample size, particularly
for VitE males. We therefore retained the treatment×sex effect in the
model and present the data while emphasizing that they should be
considered with this caveat in mind.
In fact, VitE males had significantly smaller liver TAC than males
of the other three groups (Fig. 2B). Conversely, in females the
only significant pairwise difference was observed between the
control and the VitE+Cort groups (Fig. 2B). In addition, VitE and
VitE+Cort females had larger TAC than males from their group,
while no significant sex-related differences were observed within
the other treatment groups (Fig. 2B).
Lipid peroxidation in the brain was also significantly affected by
egg treatment (Fig. 2E). Embryos from Cort eggs had significantly
lower lipid peroxidation levels than embryos from control and
VitE+Cort eggs. The difference between lipid peroxidation in the
brain of Cort and VitE embryos was similar to that between Cort and
control embryos but did not attain statistical significance (P=0.127).
No effect of egg treatment was observed on TAC in the brain, the
amount of pro-oxidants in both brain and liver, and in lipid
peroxidation in the liver (Table 4).
Sex had a significant main effect on brain mass, with males
having larger brains but not greater overall mass or tarsus length,
than females (Table 3). This effect persisted when we also
controlled in the analysis for tarsus length as a proxy for embryo
size or for embryo mass (details not shown). In addition,
independent of treatment effects, males had a lower TAC in the
liver compared with females (Table 4). No sex-related differences
existed for the other traits ( Tables 3 and 4).
Egg laying order had significant effects on tarsus length and brain
mass, with embryos from c-eggs having smaller phenotypic values
than embryos from both a- and b-eggs, while controlling for the
concomitant effects of treatment, sex and original egg mass
(Table 3). No significant variation according to laying order was
observed for the other traits ( Tables 3 and 4).
DISCUSSION
We manipulated the yolk concentrations of vitamin E,
corticosterone and both substances simultaneously in the eggs of
yellow-legged gulls and tested the effects on embryo morphology
and oxidative status shortly before hatching.
The effects of experimental manipulations on morphological
traits were largely consistent with our expectations. The injection of
a high corticosterone concentration significantly reduced embryo
mass, tarsus length and liver (though not brain) mass relative to
controls, while administration of vitamin E in combination with
corticosterone restored normal morphological traits as observed
in controls. Vitamin E supplementation did not increase size traits
relative to controls, suggesting that vitamin E is not generally
limiting for embryonic growth under natural conditions, although
this may be the case specifically for c-eggs (Parolini et al., 2015),
and beneficial effects of vitamin E supplementation may become
apparent only under the physiological conditions set by an
experimental increase in the concentration of corticosterone.
Table 4. Linear mixed models of embryo oxidative status traits in relation to egg treatment, sex and laying order
F d.f. P Males Females a-eggs b-eggs c-eggs
TAC in the brain
Treatment 1.72 3141 0.166
Sex 2.24 1141 0.137 1.61 (0.16) 1.86 (0.16)
Laying order 2.11 2141 0.125 1.92 (0.17) 1.55 (0.17) 1.75 (0.17)
TAC in the liver
Treatmenta 3.70 3137 0.013*
Sex 6.91 1137 0.0052* 1.52 (0.17) 2.00 (0.16)
Laying order 2.97 2137 0.055 1.94 (0.17) 1.51 (0.17) 1.82 (0.18)
Treatment×sexb 3.70 3137 0.0135
ROS in the brain
Treatment 1.92 3142 0.130
Sex 0.10 1142 0.756 55.6 (3.6) 56.9 (3.6)
Laying order 0.15 2142 0.863 56.2 (4.0) 55.1 (3.9) 57.5 (4.0)
ROS in the liver
Treatment 0.51 3141 0.678
Sex 0.73 1141 0.394 255.8 (9.8) 244.2 (9.6)
Laying order 0.61 2141 0.545 254.3 (11.4) 239.8 (11.5) 255.8 (11.8)
LP in the brain
Treatment 3.19 3145 0.026
Sex 2.93 1145 0.089 10.57 (0.58) 9.65 (0.58)
Laying order 0.82 2145 0.443 10.54 (0.61) 9.93 (0.61) 9.86 (0.61)
LP in the liver
Treatment 0.12 3144 0.946
Sex 0.00 1144 0.966 13.34 (0.70) 13.31 (0.70)
Laying order 2.31 2144 0.103 14.37 (0.76) 12.92 (0.75) 12.69 (0.76)
Egg treatments were: control, vitamin E, corticosterone, vitamin E+corticosterone. TAC, total antioxidant capacity; ROS, reactive oxygen species; LP, lipid
peroxidation. The non-significant two-way interaction terms between treatment, sex and laying order were excluded from the models in all cases except for the
model of TAC in the liver. The least-squares means (s.e.) for either sex or position in the laying sequence and the coefficient for egg mass are reported. For least-
squares means of the treatment groups, see Fig. 2. Asterisks indicate that the effect was statistically significant after FDR correction.
aTAC of vitamin E-treated embryos was significantly smaller than TAC from the other groups in LSD tests.
bRetained in the model although not statistically significant after FDR correction.
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However, it should be noted that vitamin E supplementation did not
fully restore normal liver mass when administered together
with corticosterone, implying that the effect of vitamin E differs
among morphological traits. Interestingly, the correlation between
corticosterone and vitamin E concentrations in the eggs of the gull
population that we studied here is relatively high (r=0.30; Rubolini
et al., 2011), though marginally non-significant, suggesting that
mothers tend to allocate more vitamin E to the eggs that also contain
larger concentrations of corticosterone, possibly to also compensate
for the negative effect of the latter on growth.
In a previous study, we showed that vitamin E at half the dose
used in the present study boosted body mass but not tarsus length of
the embryos at the same developmental stage (Parolini et al., 2017a).
Thus, different vitamin E doses seem to differentially affect
different traits. In addition, another experiment showed that the
same doses used in the present experiment depressed body mass but
not tarsus length in 4 day old chicks (whereas it had no effect at
hatching; Possenti et al., 2018a,b). Hence, the same physiological
excess of vitamin E has markedly different effects at different,
though close life stages. However, also in the previous experiment
where we focused on chicks rather than embryos, supplementation
of both compounds restored a normal phenotype in terms of body
mass at 4 days of age, again suggesting that an increase in either egg
compound concentration must be accompanied by an increase in the
other in order to attain a normal phenotype for the offspring
(Possenti et al., 2018a,b). It should also be noted that no effect of
experimental treatment on tarsus length was observed among chicks
(Possenti et al., 2018a,b), whereas it was very clearly observed here
among embryos, again implying that the effects of the two egg
compounds varies with life stage.
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Fig. 2. Oxidative status variables of embryos from control eggs and eggs injected with vitamin E, corticosterone or vitamin E plus corticosterone.
(A,B) Total antioxidant capacity (TAC) in the brain (A) and the liver (B). (C,D) Amount of pro-oxidant molecules (reactive oxidant species, ROS) in the brain (C) and
in the liver (D). (E,F) Lipid peroxidation (LP) in the brain (E) and the liver (F). Data are means±s.e.m. Horizontal lines connect pairs of groups that significantly
differed in LSD post hoc tests. Numbers above histograms indicate sample size.
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The analyses of oxidative status variables showed no effect
of experimental treatment on TAC in the brain, on ROS
concentrations in both focal organs, and on lipid peroxidation in
the liver. These results of no effect of vitamin E treatment on
oxidative status endpoints are consistent with a previous study
where we applied half the dose of vitamin E used here (Parolini
et al., 2017a).
In the present study, vitamin E supplementation depressed TAC
in the liver. This result is consistent with the negative postnatal
effect of vitamin E supplementation at the same dose as used here on
plasma TAC of chicks (Possenti et al., 2018a,b). However, such an
effect was not observed in Parolini et al. (2017a), where half the
dose used in the present study did not affect TAC in the liver of the
embryos. The reason why high, physiological concentrations of
vitamin E cause negative effects on TAC both in the liver of
embryos (present study) and in the plasma of young chicks (Parolini
et al., 2017a) remains open to speculation. As noted in Possenti et al.
(2018a,b), excess vitamin E within physiological limits is expected
not to have detrimental effects, based on studies of domestic
animals, but very little is known about the effects of vitamin E
supplementation in wild animals. In a previous study of the barn
swallow, while supplementation of nestlings with moderate doses of
vitamin E boosted body growth, supplementation with larger
amounts within physiological limits reversed the positive effects of
moderate doses (de Ayala et al., 2006). Hence, the effect of
vitamin E seems not to change linearly according to dose even
within physiological limits, not only for body growth but also for
antioxidant capacity. An alternative interpretation is that
supplementation with vitamin E changes the allocation of
antioxidants among body tissues, resulting in lowered antioxidant
capacity in the liver. It should also be noted that the negative effects
of high concentrations of vitamin E on TAC in the liver were mainly
experienced by males, as suggested by the treatment×sex interaction
effect and by the post hoc comparisons. While this pattern seems
quite obvious from the observation of the within-group and -sex
mean data presented in Fig. 2B, we emphasize that the statistical
effect of the treatment×sex interaction was significant before but not
after FDR correction, and this piece of evidence should therefore be
considered with this caveat in mind.
Corticosterone treatment appeared to lower lipid peroxidation in
the brain while normal lipid peroxidation levels were restored when
corticosterone was administered in conjunction with vitamin E. The
interpretation of this effect is open to speculation. Corticosterone
treatment caused a marked reduction in brain size, relative to the
other treatments, as shown in Fig. 1C, although the effect of
treatment was not statistically significant. We may speculate that
reduced lipid peroxidation in the brain caused by corticosterone
treatment resulted from reduced brain growth rates. Again, however,
treatment with vitamin E in association with corticosterone
administration restored normal brain lipid peroxidation while
vitamin E administration per se did not affect lipid peroxidation.
These result suggest that corticosterone and vitamin E have
contrasting effects on embryo and young chick physiology, and
that an excess of vitamin E does not affect physiological perinatal
offspring physiological traits.
Finally, we observed that males had significantly larger brains
than females after controlling for embryo size or mass. A sex
difference in brain mass is consistent with evidence from previous
studies (Parolini et al., 2017c), although it was not affected by yolk
supplementation with vitamin E, corticosterone or their mixture.
In conclusion, the present experiment suggests for the first time in
any wild bird species that corticosterone depresses prenatal
growth but such negative effects are countered by vitamin E
supplementation, implying antagonistic effects of these egg
constituents on embryonic growth. However, vitamin E seems not
to be limiting to yellow-legged gull eggs (but see Parolini et al.,
2015, for data on c-eggs). Although we injected a high, potentially
supraphysiological corticosterone concentration, it does not
undermine the conclusion that vitamin E can neutralize the
detrimental effect of this molecule. In addition, the present
results, in combination with those from previous studies, highlight
differences in the effects of different doses of vitamin E and
corticosterone on morphological and physiological traits at
different, albeit close, life stages, implying that the effects of
variation in the concentration of egg components on offspring
phenotype should not be generalized across life stages and egg
concentrations of these important compounds.
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